IMMUNOSEQ DX
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOSEQ DX Trademark

Serial Number: 88359598

IMMUNOSEQ DX is a trademark filed by Adaptive Biotechnologies Corporation on March 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Adaptive Biotechnologies Corporation (31 trademarks)

1551 Eastlake Avenue East Suite 200
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

March 27, 2019

Registration Date

Not Registered

Published for Opposition

December 31, 2019

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 27, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 27, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2021 EXRA
SOU EXTENSION 2 GRANTED
Feb 25, 2021 EX2G
SOU EXTENSION 2 FILED
Feb 25, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 25, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2020 EXRA
SOU EXTENSION 1 GRANTED
Aug 21, 2020 EX1G
SOU EXTENSION 1 FILED
Aug 21, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 21, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
ASSIGNED TO LIE
Nov 22, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 4, 2019 GPRN
PRIORITY ACTION E-MAILED
Jun 4, 2019 GPRA
PRIORITY ACTION WRITTEN
Jun 4, 2019 CPRA
ASSIGNED TO EXAMINER
May 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2019 NWOS
NEW APPLICATION ENTERED
Mar 30, 2019 NWAP